Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Omalizumab boosts tolerance to multiple food allergies, study finds

A study in The New England Journal of Medicine shows omalizumab increases allergen tolerance in individuals with multiple food allergies, offering a promising standalone treatment option.

26 Feb 2024

Study reveals how long COVID can affect brain function through vascular disruption

The neurological response to coronavirus disease 2019 (COVID-19) may be due to brain-brain barrier (BBB) disruption.

26 Feb 2024

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Identifying antiviral protein IFN-γ as a potential biomarker for Long COVID

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies.

24 Feb 2024

Florida defies CDC in measles outbreak, telling parents it’s fine to send unvaccinated kids to school

With a brief memo, Florida Surgeon General Joseph Ladapo has subverted a public health standard that's long kept measles outbreaks under control.

23 Feb 2024

How did COVID-19 impact cancer incidence trends in the US?

Cancer rate patterns from March to December 2020.

23 Feb 2024

Females' immune system edges out males but at a cost of higher autoimmune risk

A review article highlights how two X chromosomes in females influence immune system composition and function, leading to faster infection clearance and stronger vaccination responses but also a higher risk of autoimmune diseases.

22 Feb 2024

Elevated IFN-γ levels linked to long COVID, study finds

Researchers find elevated IFN-γ levels in long COVID patients, with symptom improvement correlating with decreased IFN-γ, suggesting it as a potential biomarker and target for therapeutic intervention.

22 Feb 2024

Persistent COVID-19 could drive virus evolution, new study suggests

Study reveals the prevalence of persistent SARS-CoV-2 infection in the UK, showing its potential role in viral evolution and the emergence of new variants, with implications for long-COVID and public health strategies.

22 Feb 2024

Major discovery improves the understanding of brain fog associated with Long COVID

Today, a team of scientists from Trinity College Dublin and investigators from FutureNeuro announced a major discovery that has profound importance for our understanding of brain fog and cognitive decline seen in some patients with Long COVID.

22 Feb 2024

COVID-19's neurological effects linked to immune response, not direct viral attack

Study identifies neurocognitive symptoms in COVID-19 patients as a reaction to systemic infection rather than direct brain infection, highlighting changes in the brain's immune response and synaptic organization.

21 Feb 2024

Study highlights an immunological mechanism underlying Long COVID

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression.

21 Feb 2024

Study reveals high prevalence of persistent COVID-19 infections in general population

A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more.

21 Feb 2024

Physical activity counters social isolation's mental toll

Physical activity significantly offsets the negative impact of social isolation on mental health, with neuroimaging showing its potential as a compensatory mechanism for emotional well-being.

20 Feb 2024

COVID-19 linked to higher fatigue rates, says study

A study by the CDC and Washington University found COVID-19 significantly increases the risk of developing fatigue and chronic fatigue, with higher incidence rates compared to non-COVID-19 controls.

19 Feb 2024

Survey of US adults reveals common cognitive symptoms in post-COVID-19 patients, linked to impaired daily functioning and depression

Scientists examined how prevalent self-reported cognitive symptoms were in individuals with post-COVID-19 condition as compared to individuals who had prior severe SARS-CoV-2 infections but had not developed post-COVID-19 condition.

19 Feb 2024